Drug failure pushes pharma giant to lower forecasts for 2019
Iseq Overall Index dips 0.09 per cent to 5,651.16 in Dublin as CRH slips 1.83 per cent
The move to buy Loxo Oncology is the second multibillion-dollar cancer deal of the year by a major US pharma giant
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices